Expedient Method for the Solid-Phase Synthesis of Aspartic Acid Protease Inhibitors Directed toward the Generation of Libraries

Journal of Medicinal Chemistry

Volumn 38, Issue 9, 1995, Pages 1427-1430

  Kick, Ellen K ^a   Ellman, Jonathan A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ASPARTIC ACID; L 738872; PROTEINASE INHIBITOR; SAQUINAVIR; TELINAVIR; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ARTICLE; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; SOLID PHASE EXTRACTION;

ASPARTIC ENDOPEPTIDASES; HIV PROTEASE INHIBITORS; HIV-1; SUPPORT, NON-U.S. GOV'T;

EID: 0028968619     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00009a002     Document Type: Article

References (29)

1. Dunn, B. M., Ed. Structure and Function of the Aspartic Proteinoses; Plenum Press: New York, 1991.
2. Greenlee, W. J. Renin Inhibitors. Med. Res. Rev. 1990, 10, 173-236.
3. Wiley, R. A.; Rich, D. H. Peptidomimetics Derived from Natural Products. Med. Res. Rev. 1993, 13, 327-384.
4. Baldwin, E. T.; Bhat, T. N.; Gulnik, S.; Hosur, M. V.; Sowder, R. C.; Cachau, R. E.; Collins, J.; Silva, A. M.; Erickson, J. W. Crystal Structures of Native and Inhibited Forms of Human Cathepsin D: Implication for Lysosomal Targeting and Drug Design. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 6796-6800.
5. Roberts, N. A.; Martin, J. A.; Kinchington, D.; Broadhurst, A. V.; Craig, J. C.; Duncan, I. B.; Galpin, S. A.; Handa, B. K.; Kay, J.; Krohn, A.; Lambert, R. W.; Merrett, J. H.; Mills, J. S.; Parkes, K. E. B.; Redshaw, S.; Ritchie, A. J.; Taylor, D. L.; Thomas, G. J.; Machin, P. J. Rational Design of Peptide-Based HIV Proteinase Inhibitors. Science 1990, 248, 358-361 (Ro 31-8959).
6. Getman, D. P.; DeCrescenzo, G. A.; Heintz, R. M.; Reed, K. L.; Talley, J. J.; Bryant, M. L.; Clare, M.; Houseman, K. A.; Marr, J. J.; Mueller, R. A.; Vazquez, M. L.; Shieh, H-S.; Stallings, W. C.; Stegeman, R. A. Discovery of a Novel Class of Potent HIV-1 Protease Inhibitors Containing the (R)-(Hydroxyethyl) urea Isostere. J. Med. Chem. 1993, 36, 288-291.
7. Kim, B. M.; Vacca, J. P.; Guare, J. P.; Hanifin, C. M.; Michelson, S. R.; Darke, P. L.; Zugay, J. A.; Emini, E. A.; Schleif, W.; Lin, J. H.; Chen, I.-W.; Vastag, K.; Ostovic, D.; Anderson, P. S.; Huff, J. R. A New Hydroxyethy- lamine Class of HIV-1 Protease Inhibitors with High Antiviral Potency and Oral Bioavailability. BioMed. Chem. Lett. 1994, 4, 2273-2278 (L-738, 872).
8. Kim, E. E.; Baker, C. T.; Dwyer, M. D.; Murcko, M. A.; Rao, B. G.; Tung, R. D.; Navia, M. A. Crystal Structure of HIV-1 Protease in Complex with VX-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme. J. Am. Chem. Soc. 1995, 117, 1181-1182 (VX-478).
9. Smith, A. B.; Hirschmann, R.; Pasternak, A.; Akaishi, R.; Guzman, M. C.; Jones, D. R.; Keenan, T. P.; Sprengeler, P. A.; Darke, P. L.; Emini, E. A.; Holloway, M. K.; Schleif, W. A. Design and Synthesis of Peptidomimetic Inhibitors of HIV-1 Protease and Renin. Evidence for Improved Transport. J. Med. Chem. 1994, 37, 215-218.
10. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Chang, C.-H.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Viitanen, S. Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors. Science 1994, 263, 380-384.
11. Norbeck, D.; Kempf, D.; Marsh, K; Paul, D. Knigge, M.; Vasavanonda, S.; Clement, J.; Kohlbrenner, W.; Sham, H.; Wideburg, N.; Plattner, J. Discovery of Potent, Orally Bioavailable Inhibitors of HIV Protease. In Discovery of Potent, Orally Bioavailable Inhibitors of HIV Protease; VII International Conference on AIDS; Amsterdam, 1992.
12. Varney, M. D.; Appelt, K; Kalish, V.; Reddy, M. R.; Tatlock, J.; Palmer, C. L.; Romines, W. H.; Wu, B.-W.; Musick, L. Crystal-Structure-Based Design and Synthesis of Novel C-Terminal Inhibitors of HIV Protease. J. Med. Chem. 1994, 37, 2274-2284.
13. Huff, J. R. HIV Protease: A Novel Chemotherapeutic Target for AIDS. J. Med. Chem. 1991, 34, 2305-2314.
14. Wlodawer, A.; Erickson, J. W. Structure-Based Inhibitors of HIV-1 Protease. Annu. Rev. Biochem. 1993, 62, 543-585.
15. Journal of Medicinal Chemistry, 1995, Vol. 38, No. 9.
16. Saiga, A.; Tanaka, T.; Orita, S.; Sato, A.; Sato, S.; Hachisu, T.; Abe, K.; Kimura, Y.; Kondo, Y.; Fujiwara, T.; Igarashi, H. Human T-cell Leukemia Virus Type 1 Protease Protein Expressed in Escherichia coli Possesses Aspartic Proteinase Activity. Arch. Virol. 1993, 128, 195-210.
17. Fusek, M.; Smith, E. A.; Monod, M.; Dunn, B.; Foundling, S. I. Extracellular Aspartic Proteinases from Candida albicans, Candida tropicalis, and Candida parapsilosis Yeasts Differ Substantially in Their Specificities. Biochemistry 1994, 33, 9791-9799.
18. Owens, R. A.; Gesellchen, P. D.; Houchins, B. J.; DiMarchi, R. D. The Rapid Identification of HIV Protease Inhibitors Through the Synthesis and Screening of Defined Peptide Mixtures. Biochem. Biophys. Res. Commun. 1991, 181, 402-408.
19. Ghosh, A. K.; McKee, S. P.; Lee, H. Y.; Thompson, W. J. A Facile and Enantiospecific Synthesis of 2 (S)- and 2CR)-[1′ (S)- Azido-2-phenylethyl] oxirane. J. Chem. Soc., Chem. Commun. 1992, 273-274.
20. Caron, M.; Carlier, P. R.; Sharpless, K. B. Regioselective Azide Opening of 2, 3-Epoxy Alcohols by [TifO-i-Pr23) 2]: Synthesis of a-Amino Acids. J. Org. Chem. 1988, 53, 5185-5187.
21. Thompson, L. A.; Ellman, J. A. Straightforward and General Method for Coupling Alcohols to Solid Supports. Tetrahedron Lett. 1994, 35, 9333-9336.
22. Majer, P.; Randad, R. S. A Safe and Efficient Method for Preparation of N-N’-Unsymmetrically Disubstituted Ureas Utilizing Triphosgene. J. Org. Chem. 1994, 59, 1937-1938.
23. Krchnak, V.; Vagner, J.; Safar, P.; Lebl, M. Noninvasive Continuous Monitoring of Solid-phase peptide Synthesis by Acid-base Indicator. Czech. Chem. Commun. 1988, 53, 2542-2548.
24. Raddatz, P.; Schmitges, C. J.; Minck, K. O. Amino Acid Derivatives. Eur. Pat. Appl. 264, 795, 1987.
25. Bartra, M.; Romea, P.; Urpi, F.; Vilarrasa, J. A Fast Procedure for the Reduction of Azides and Nitro Compounds Based on the Reducing Ability of Sn (SR) 3‘ Species. Tetrahedron 1990, 46, 587-594.
26. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color Test for Detection of Free Terminal Amino Groups in the Solid-Phase Synthesis of Peptides. Anal. Biochem. 1970, 34, 595-598.
27. Cho, S. Y. S.; Jungheim, L. N.; Baxter, A. J. Novel HIV-1 Protease Inhibitors Containing a β-Hydroxy Sulfide Isostere. Biomed. Chem. Lett. 1994, 4, 715-720.
28. Ghosh, A. K.; Duong, T. T.; McKee, S. P.; Thompson, W. J. NJ\T‘- Disuccinimidyl Carbonate: A Useful Reagent for Alkoxycarbo- nylation of Amines. Tetrahedron Lett. 1992, 33, 2781-2784.
29. Ghosh, A. K.; Thompson, W. J.; McKee, S. P.; Duong, T. T.; Lyle, T. A.; Chen, J. C.; Darke, P. L.; Zugay, J. A.; Emini, E. A.; Schleif, W. A.; Huff, J. R.; Anderson, P. S. 3-Tetrahydrofuran and Pyran Urethanes as High-Affinity P2-Ligands for HIV-1 Protease Inhibitors. J. Med. Chem. 1993, 36, 292-294.